DrugPatentWatch Database Preview
Neopharma Company Profile
What is the competitive landscape for NEOPHARMA, and what generic and branded alternatives to NEOPHARMA drugs are available?
NEOPHARMA has five approved drugs.
Summary for Neopharma
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Neopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neopharma | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 078383-002 | Mar 12, 2013 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | IRBESARTAN | irbesartan | TABLET;ORAL | 203161-003 | Sep 27, 2012 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 078383-001 | Mar 12, 2013 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 079049-001 | Aug 4, 2008 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078953-002 | Apr 15, 2010 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 079049-004 | Aug 4, 2008 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
